Trial intelligence / Profile preview

Early topical mitomycin for pediatric corrosive esophagitis

PACTR202301748506567Phase 2Completed

Sponsor
Pediatric Endoscopy Center, Cairo University
Start
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of mitomycin c in esophagitis (2 arms), sponsored by Pediatric Endoscopy Center, Cairo University. Primary endpoint: Efficacy of topical mitomycin in reducing subsequent esophageal stricture. Started Dec 2020; status: completed.

02

Drugs

mitomycin c
03

Conditions

esophagitis

Beyond the preview

Go deeper on PACTR202301748506567.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202301748506567.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call